4
Changes in Ownership
Protagenic Therapeutics, Inc.\new Filed Acc 0001144204-07-011311
10% owner bought 720,000,000 shares at $0.01 ($6,984,000)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Trinad Capital Master Fund Ltd. 10% owner | 2007-02-12 | Purchase | +360,000,000 | $0.01 | $3,492,000 | 429,750,000 | D: show line 1 in the form |
| Trinad Capital Master Fund Ltd. 10% owner | 2007-02-12 | Purchase | +360,000,000 | $0.01 | $3,492,000 | 429,750,000 | I: show line 2 in the form |
| Open-market purchases · 720,000,000 sh · avg $0.01 · $6,984,000 | |||||||
Loading xslF345X02/v067658_ex.xml…